Skip to main content
. 2021 Dec 14;9:753487. doi: 10.3389/fpubh.2021.753487

Table 4.

Chronic diseases, TX CARES, all phase 1 participants, 2020.

Chronic disease Overall (n = 270) SARS-CoV2 antibody status
Positive (n = 68) Negative (n = 193)
N (%) N (%) N (%)
Asthma 56 (20.7) 18 (26.5) 33 (17.1)
COPD 4 (1.5) 1 (1.5) 2 (1.0)
Cancer 7 (2.6) 0 (0.0) 7 (3.6)
Cardiovascular 8 (3.0) 2 (2.9) 5 (2.6)
Diabetes 56 (20.7) 18 (26.5) 35 (18.1)
Hypertension 83 (30.7) 21 (30.9) 58 (30.1)
Obesity 60 (22.2) 14 (20.6) 43 (22.3)
Sickle cell 0 (0.0) 0 (0.0) 0 (0.0)
Immunocompromised 8 (3.0) 1 (1.5) 6 (3.1)
Kidney disease 2 (0.7) 0 (0.0) 2 (1.0)
Other 17 (6.3) 2 (2.9) 13 (6.7)